FDA.reportPublic FDA data

DESVENLAFAXINE SUCCINATE

Substance profile for UNII ZB22ENF0XR, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for DESVENLAFAXINE SUCCINATE
Structure render from PubChem CID 6918664

Substance Identity#

UNII
ZB22ENF0XR
Preferred term
DESVENLAFAXINE SUCCINATE
Registry number
386750-22-7
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C16H25NO2.C4H6O4.H2O
Chemical structure for DESVENLAFAXINE SUCCINATE
Structure render from PubChem CID 6918664

Chemical And Database Identifiers#

SMILES
O.OC(=O)CCC(O)=O.CN(C)CC(C1=CC=C(O)C=C1)C2(O)CCCCC2
RxCUI
683693
PubChem
6918664
NCIt
C61704
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound6918664https://pubchem.ncbi.nlm.nih.gov/compound/6918664
RxNorm683693https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=683693
NCI ThesaurusC61704https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61704
FDA Substance Registration SystemZB22ENF0XRhttps://precision.fda.gov/uniisearch/srs/unii/ZB22ENF0XR

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
DESVENLAFAXINE SUCCINATEACTIVE INGREDIENTZB22ENF0XRThese highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, oral Initial U.S. Approval: 20081
DESVENLAFAXINE SUCCINATEACTIVE INGREDIENTZB22ENF0XRPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3747
DESVENLAFAXINE SUCCINATEACTIVE INGREDIENTZB22ENF0XRPRISTIQ EXTENDED RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2068
DESVENLAFAXINE SUCCINATEACTIVE INGREDIENTZB22ENF0XRPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]47
DESVENLAFAXINE SUCCINATEACTIVE INGREDIENTZB22ENF0XRPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [CARDINAL HEALTH]10
DESVENLAFAXINE SUCCINATEACTIVE INGREDIENTZB22ENF0XRDESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [BRECKENRIDGE PHARMACEUTICAL, INC]7
DESVENLAFAXINE SUCCINATEACTIVE INGREDIENTZB22ENF0XRPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]1